4.5 Article

Acyl-coenzyme A Cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines

Journal

CANCER BIOLOGY & THERAPY
Volume 9, Issue 12, Pages 1025-1032

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.9.12.11875

Keywords

glioma; ACAT; apoptosis; cholesterol; caspases

Categories

Funding

  1. Centre of Research clinic Etienne-Le-Bel [PAFI-08]
  2. University of Sherbrooke
  3. CIHR

Ask authors/readers for more resources

Glioblastoma is the most common primary brain tumor in adults and one of its hallmarks is resistance to apoptosis. Acyl-CoA: cholesterol acyltransferase (ACAT) is an intracellular membrane-bound enzyme that uses cholesterol and long chain fatty acyl-CoA as substrates to produce cholesteryl esters. The presence of cholesteryl esters in glioblastoma may be related to vascular and/or cell neoplastic proliferation in the tumor mass, two prerequisites for tumor cell growth. ACAT activity has been detected in glioblastoma cell homogenates. The present study is the first report on the effect of Avasimibe, a specific inhibitor of ACAT, on glioma cell lines (U87, A172 and GL261). Our results showed that Avasimibe inhibited ACAT-1 expression and cholesterol ester synthesis in glioma cell lines. Moreover, Avasimibe inhibited the growth of the cells by inducing cell cycle arrest and induced apoptosis as a result of caspase-8 and caspase-3 activation. Also, Our findings provide proof of principle that targeting ACAT-1 with the inhibitor Avasimibe could be an efficient therapy in the treatment of glioblastoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available